In pharmaceutical cleanrooms, airflow visualization helps teams understand how air moves around exposed products, critical surfaces, equipment, and operators during aseptic operations.
But recording a smoke study is only half the job.
The recorded footage must be reviewed to determine whether it provides sufficient evidence of airflow protection under the conditions defined in the approved protocol. This is where a structured Smoke Study Video Review becomes important.
For Quality Assurance (QA), validation, and engineering teams, the challenge is not simply identifying unusual smoke movement. It is determining what the observation means, whether it meets predefined acceptance criteria, and how the conclusion should be documented.
Here is a practical nine-point checklist for reviewing smoke study footage.
1. Verify the Study Configuration
Before interpreting the airflow, confirm that the video represents the approved study setup.
Check:
- Protocol version and study identification.
- Room and equipment configuration.
- Smoke source and test conditions.
- At-rest or in-operation state.
- Relevant supporting airflow measurements.
If the recorded setup differs from the approved protocol, document the discrepancy and evaluate its impact before accepting the results.
This prevents reviewers from drawing conclusions from footage that does not represent the intended conditions.
2. Check Whether Critical Areas Are Visible
A video may contain extensive footage but still fail to demonstrate what matters.
Review whether the camera clearly captures the exposed product, critical surfaces, relevant equipment, and operator activities.
For example, if an operator's arm blocks the view of a filling point during an intervention, the reviewer may be unable to determine whether airflow protection was maintained.
Record the timestamp and location of any visibility gap. Then assess whether the available evidence is sufficient or whether supplementary footage or repeat testing is needed.
3. Evaluate First-Air Protection
First air is filtered air that reaches exposed product or critical surfaces before contacting other objects that could compromise its protective function.
During the review, follow the visible airflow path toward the critical zone.
Ask:
- Does the airflow reach the exposed product as intended?
- Do operator movements interfere with the airflow path?
- Does equipment obstruct the intended air movement?
- Is there evidence of a potential contamination risk?
EU GMP Annex 1 paragraphs 4.4 and 4.19 address protection of critical zones and first-air protection in relevant contexts.
An observation should be assessed against the approved protocol and supporting evidence rather than classified as a failure based on appearance alone.
4. Review Dynamic Operations and Operator Interventions
Airflow can behave differently when operators perform routine activities.
Examples include material replenishment, equipment adjustments, and interventions near critical processing areas.
Compare the recorded activities with the interventions defined in the approved protocol. Check whether the footage represents the intended operating conditions and whether important activities are missing.
EU GMP Annex 1 paragraph 8.16 addresses authorized lists of inherent and corrective interventions, taking their potential impact on airflow into account.
If a critical intervention was not recorded, document the gap and assess whether the study remains adequate for its intended purpose.
5. Interpret Turbulence and Reversal in Context
Smoke visualization may show eddies, turbulence, temporary reversals, or changes in airflow direction.
These observations are not automatically failures.
Their significance depends on factors such as:
- Location of the disturbance.
- Duration and frequency.
- Proximity to exposed products.
- Interaction with operator movements or equipment.
- Evidence of maintained or restored protection.
For example, a temporary disturbance away from a critical surface may require a different assessment from airflow that visibly carries contamination from an operator toward an exposed product.
The review should document what was observed, evaluate the potential risk, and compare the evidence with the approved acceptance criteria.
6. Verify Coverage of Critical Locations
A review should confirm that all protocol-defined locations and scenarios are represented in the footage.
Depending on the facility, these may include filling points, exposed product pathways, equipment interfaces, and locations affected by interventions.
For barrier systems, EU GMP Annex 1 paragraph 4.20 addresses airflow pattern studies at relevant open-isolator interfaces and during RABS interventions, including door openings.
A simple location-by-location review can help identify missing evidence before the final report is approved.
7. Compare Findings with Predefined Acceptance Criteria
Once observations have been recorded, compare them with the approved acceptance criteria.
Avoid relying solely on subjective descriptions such as “good airflow” or “acceptable smoke movement.” The reviewer should explain how the evidence supports the conclusion required by the protocol.
Acceptance criteria should be established before reviewing the results. If they are inadequate, the issue should be addressed through the site's quality and change-control procedures rather than by adjusting criteria to fit the observed outcome.
Neither EU GMP Annex 1 nor the FDA's aseptic processing guidance provides a universal set of pass/fail thresholds for every smoke study video review.
8. Document Deviations and Follow-Up Actions
Unexpected airflow patterns, incomplete footage, or differences between the approved and actual setup may require investigation.
A useful review record should identify:
- The observation and timestamp.
- The affected location and operating activity.
- The relevant acceptance criterion.
- The potential impact on product protection.
- The conclusion and required follow-up.
Where necessary, follow the site's deviation management process and determine whether corrective and preventive actions (CAPA) are appropriate.
If footage contains repeated takes or edited clips, retain the original recordings and document why the additional versions were created.
9. Maintain Video and Report Traceability
The final check is documentation integrity.
Verify that:
- Video file identifiers match the report.
- Timestamps correspond to the observation log.
- Location labels are consistent.
- Original recordings are retained alongside edited clips.
- Deviations and follow-up actions are traceable.
- Final conclusions match the approved protocol and acceptance criteria.
EU GMP Annex 1 paragraph 4.15 addresses the retention of airflow visualization recordings and documentation of outcomes.
Traceability allows another qualified reviewer to understand the evidence and follow the reasoning behind the final decision.
A Practical Example: Reviewing an Airflow Observation
Consider a hypothetical scenario in which smoke near an operator's forearm briefly moves toward an exposed product during a manual intervention.
The reviewer should not immediately classify the study as failed.
Instead, the review should establish:
- Observation: Smoke movement toward the critical area.
- Context: The intervention being performed and the location involved.
- Evidence: The complete video sequence and relevant supporting data.
- Assessment: Whether the movement compromises the protection required by the approved protocol.
- Outcome: A documented conclusion and any necessary investigation or repeat testing.
This approach separates an observation from the decision made about it.
How EU GMP Annex 1 and FDA Guidance Fit Into the Review
EU GMP Annex 1 (2022), paragraph 4.15, addresses airflow visualization at rest and in operation, with video recordings retained and outcomes documented.
The FDA's guidance on sterile drug products produced by aseptic processing also discusses in situ airflow pattern analysis under dynamic conditions and documentation of conclusions.
These sources provide regulatory context for smoke study evaluation. However, the nine checks in this article are a practical review framework, not a verbatim regulatory checklist.
Facilities should define responsibilities, acceptance criteria, and documentation requirements through their approved protocols and quality systems.
Final Thoughts
A reliable Smoke Study Video Review requires more than watching smoke move through a cleanroom. It requires reviewers to connect the recorded evidence with the study protocol, operational conditions, contamination risks, and documented acceptance criteria.
For QA and validation teams, a structured checklist makes it easier to identify missing evidence, investigate potential concerns, and explain the final decision.
For a more detailed guide, see Smoke Study Video Review: 9 Essential Checks for QA Teams.
You can also explore IncepBio's cleanroom validation services for information about static and dynamic smoke studies in pharmaceutical manufacturing.
This article is intended for educational purposes. Study-specific decisions should follow applicable regulatory requirements, approved protocols, risk assessments, and site procedures.
Top comments (0)